NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells

Abstract

The aim of this study was to evaluate the metabolic profile of human prostate cancer cells that have different metastatic potential and to determine their response to dichloroacetate (DCA) using NMR technology. Two isogenic human prostate cancer cell lines, differing in their metastatic potential [LNCaP (poorly metastatic) and LNCaP-LN3 (highly metastatic)], were studied. Metabolite ratios from NMR spectral integrals acquired at a field strength of 9.4 T using a 5-mm broadband probe with an NMR-compatible bioreactor were compared in the presence and absence of the pyruvate dehydrogenase kinase inhibitor DCA. Lactate dehydrogenase (LDH) isoenzymes were assessed by zymography. Following the treatment of cells with 50 mm DCA, there was a significant reduction in the lactate/choline, lactate/creatine, lactate/alanine and the combined lactate/(choline + creatine + alanine) ratios in LNCaP-LN3 cells relative to LNCaP cells. No significant changes in metabolite ratios were found in LNCaP cells following DCA treatment. As expected, LDH zymography assays showed an absence of the LDH-B subunit in LNCaP-LN3 cells, whereas both LDH-A and LDH-B subunits were present in LNCaP cells. DCA was shown to significantly modify the metabolite ratios in highly metastatic LNCaP-LN3 cells, but not in poorly metastatic LNCaP cells. This effect was probably related to the absence of the LDH-B subunit in LNCaP-LN3 cells, and could have a bearing on cancer treatment with DCA and related compounds. © 2014 The Authors. NMR in Biomedicine published by John Wiley & Sons, Ltd.

In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging

“…Other studies in breast and prostate cell lines showed that lactate production is reduced upon DCA treatment (41)(42)(43). We observed that lactate production was reduced following DCA treatment both in vitro, just after 24 h, as well as in vivo, with a marked decrease in lactate levels after three days of treatment.…”

MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors

“…After exposure to 10 µM of MEK inhibitor, H295R cells presented a significantly higher lactate/alanine ratio and a higher mitochondrial membrane potential after 12 and 24 hours of treatment. The increased lactate/alanine ratio is associated with cellular redox state reflecting the intracellular NADH/NAD+equilibrium . The redox system is essential in maintaining cellular homeostasis and when a redox imbalance occurs, due to higher production of reactive oxygen species (ROS) or a decrease in endogenous protective antioxidants, cells become vulnerable to apoptosis and necrosis.…”

Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via 1H nuclear magnetic resonance spectroscopy

“…A major challenge facing clinicians in the management of patients is to distinguish a lethal metastatic stage from the relatively indolent stages. Although numerous researches have shown that the metastatic progression is closely related to cellular metabolism (Kailavasan et al, ), the detailed metabolic changes and their corresponding molecular mechanism still kept unclear. The variations of metabolites are better indicators of enzyme activity.…”